Terug
Research line 'Thrombocytopathies'
Research line 'Thrombocytopathies'
Research line 'Thrombocytopathies'
'Thrombocytopathies' is one of our research lines that has a strong translational character.
Research includes both studies that are initiated by our researchers and studies that are being performed on behalf of pharmaceutical companies. An overview of currently active studies at the Van Creveldkliniek is shown in the table below.
| Study | Patient population | Description |
|---|---|---|
| Glanzmann-NHS | Pediatric and adult patients with Glanzmann Thrombastenia | Registry |
| TiN | Pediatric and adult patients with any type of thrombopathy | Thrombopathy in the Netherlands. |
| VAYHIT2 | Adult patients with Immune Thrombocytopenia (ITP) | A study to evaluate the effect ianalumab + eltrombopag for subjects who had insufficient response or relapsed after 1st line steroid treatment |
Contact
Do you have any questions about participation in one of our studies? Or do you want to get in touch with one of our researchers? Please feel free to contact the research team of the Van Creveldkliniek.
Telefoonnummer: +31 (0)88 75 584 50
Email adres: vck-research@umcutrecht.nl